The mission of the Impact of Neutropenia in Chemotherapy European study group (INC-EU) is to raise awareness and prevent the occurrence of chemotherapy-induced neutropenia (CIN) by assessing the incidence, consequences and patient risk factors and by identifying and developing accurate prediction models for CIN, such that high-risk patients can effectively be targeted for preventative measures.